# Clinical Utility Trial for the SomaLogic CVD-T2D Test

> **NCT05237271** · NA · COMPLETED · sponsor: **Qure Healthcare, LLC** · enrollment: 251 (actual)

## Conditions studied

- Cardiovascular Diseases
- Type 2 Diabetes

## Interventions

- **OTHER:** Educational Materials on the Cardiovascular Disease in Type 2 Diabetes (CVD-T2D)
- **OTHER:** Educational Materials on the CVD-T2D and Bundled Metabolic Panel

## Key facts

- **NCT ID:** NCT05237271
- **Lead sponsor:** Qure Healthcare, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-15
- **Primary completion:** 2022-08-15
- **Final completion:** 2022-08-15
- **Target enrollment:** 251 (ACTUAL)
- **Last updated:** 2022-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05237271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05237271, "Clinical Utility Trial for the SomaLogic CVD-T2D Test". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05237271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*